Is France Attractive for Pharma Companies - Comparisons & Recommendations

This new?position paper?supplements the?320-page report?entitled “The French Pharma Market 2022 - 2027 - Strategic Implications for Pharma companies” that we have released earlier this month (click on the following links to have access to the report?excerpts?and the?order form).

Smart Pharma Consulting has evaluated the?France's attractiveness for pharma companies?– by?comparison with?Germany,?Italy,?UK?and?Spain?– through four key dimensions:

... and made?recommendations?to enhance it.

Best regards,